Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Schwab MH, Nave K, Fratta P, D'Antonio M, Poitelon Y, Feltri ML, Wrabetz L.

Hum Mol Genet. 2019 Jul 1;28(13):2282. doi: 10.1093/hmg/ddz037. No abstract available.

2.

Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice.

Volpi VG, Ferri C, Fregno I, Del Carro U, Bianchi F, Scapin C, Pettinato E, Solda T, Feltri ML, Molinari M, Wrabetz L, D'Antonio M.

PLoS Genet. 2019 Apr 17;15(4):e1008069. doi: 10.1371/journal.pgen.1008069. eCollection 2019 Apr.

3.

Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Schwab MH, Nave K, Fratta P, D'Antonio M, Poitelon Y, Feltri ML, Wrabetz L.

Hum Mol Genet. 2019 May 15;28(10):1752. doi: 10.1093/hmg/ddz021. No abstract available.

4.

Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Schwab MH, Nave K, Fratta P, D'Antonio M, Poitelon Y, Feltri ML, Wrabetz L.

Hum Mol Genet. 2019 Apr 15;28(8):1260-1273. doi: 10.1093/hmg/ddy420. Erratum in: Hum Mol Genet. 2019 May 15;28(10):1752. Hum Mol Genet. 2019 Jul 1;28(13):2282.

PMID:
30535360
5.

Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model.

Scapin C, Ferri C, Pettinato E, Zambroni D, Bianchi F, Del Carro U, Belin S, Caruso D, Mitro N, Pellegatta M, Taveggia C, Schwab MH, Nave KA, Feltri ML, Wrabetz L, D'Antonio M.

Hum Mol Genet. 2019 Mar 15;28(6):992-1006. doi: 10.1093/hmg/ddy411.

PMID:
30481294
6.

A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function.

Fratta P, Ornaghi F, Dati G, Zambroni D, Saveri P, Belin S, D'Adamo P, Shy M, Quattrini A, Laura Feltri M, Wrabetz L.

Hum Mol Genet. 2019 Jan 1;28(1):124-132. doi: 10.1093/hmg/ddy336.

7.

Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model.

Florio F, Ferri C, Scapin C, Feltri ML, Wrabetz L, D'Antonio M.

J Neurosci. 2018 May 2;38(18):4275-4287. doi: 10.1523/JNEUROSCI.0201-18.2018. Epub 2018 Apr 2.

8.

Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.

Kwon JM, Matern D, Kurtzberg J, Wrabetz L, Gelb MH, Wenger DA, Ficicioglu C, Waldman AT, Burton BK, Hopkins PV, Orsini JJ.

Orphanet J Rare Dis. 2018 Feb 1;13(1):30. doi: 10.1186/s13023-018-0766-x. Review.

9.

A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.

Poitelon Y, Matafora V, Silvestri N, Zambroni D, McGarry C, Serghany N, Rush T, Vizzuso D, Court FA, Bachi A, Wrabetz L, Feltri ML.

J Neurochem. 2018 May;145(3):245-257. doi: 10.1111/jnc.14295. Epub 2018 Feb 13.

10.

Impairment of protein degradation and proteasome function in hereditary neuropathies.

VerPlank JJS, Lokireddy S, Feltri ML, Goldberg AL, Wrabetz L.

Glia. 2018 Feb;66(2):379-395. doi: 10.1002/glia.23251. Epub 2017 Oct 27.

11.

Slick (Kcnt2) Sodium-Activated Potassium Channels Limit Peptidergic Nociceptor Excitability and Hyperalgesia.

Tomasello DL, Hurley E, Wrabetz L, Bhattacharjee A.

J Exp Neurosci. 2017 Sep 14;11:1179069517726996. doi: 10.1177/1179069517726996. eCollection 2017.

12.

Acetyl-CoA production from pyruvate is not necessary for preservation of myelin.

Della-Flora Nunes G, Mueller L, Silvestri N, Patel MS, Wrabetz L, Feltri ML, Poitelon Y.

Glia. 2017 Oct;65(10):1626-1639. doi: 10.1002/glia.23184. Epub 2017 Jun 28.

13.

Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination.

Ghidinelli M, Poitelon Y, Shin YK, Ameroso D, Williamson C, Ferri C, Pellegatta M, Espino K, Mogha A, Monk K, Podini P, Taveggia C, Nave KA, Wrabetz L, Park HT, Feltri ML.

PLoS Biol. 2017 Jun 21;15(6):e2001408. doi: 10.1371/journal.pbio.2001408. eCollection 2017 Jun.

14.

Axon degeneration: Linking axonal bioenergetics to myelin.

Beirowski B, Babetto E, Wrabetz L.

J Cell Biol. 2016 Nov 21;215(4):437-440.

15.

Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.

Sidoli M, Musner N, Silvestri N, Ungaro D, D'Antonio M, Cavener DR, Feltri ML, Wrabetz L.

J Neurosci. 2016 Nov 2;36(44):11350-11361.

16.

Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.

Zhu H, Ornaghi F, Belin S, Givogri MI, Wrabetz L, Bongarzone ER.

J Neurosci Res. 2016 Dec;94(12):1520-1530. doi: 10.1002/jnr.23839. Epub 2016 Jul 18.

17.

Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.

Weinstock NI, Wrabetz L, Feltri ML, Shin D.

J Neurosci Res. 2016 Nov;94(11):1094-107. doi: 10.1002/jnr.23789.

18.

Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe's disease presymptomatically?

Carter RL, Wrabetz L, Jalal K, Orsini JJ, Barczykowski AL, Matern D, Langan TJ.

J Neurosci Res. 2016 Nov;94(11):1084-93. doi: 10.1002/jnr.23793.

PMID:
27638594
19.

YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.

Poitelon Y, Lopez-Anido C, Catignas K, Berti C, Palmisano M, Williamson C, Ameroso D, Abiko K, Hwang Y, Gregorieff A, Wrana JL, Asmani M, Zhao R, Sim FJ, Wrabetz L, Svaren J, Feltri ML.

Nat Neurosci. 2016 Jul;19(7):879-87. doi: 10.1038/nn.4316. Epub 2016 Jun 6.

20.

Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.

Musner N, Sidoli M, Zambroni D, Del Carro U, Ungaro D, D'Antonio M, Feltri ML, Wrabetz L.

ASN Neuro. 2016 Apr 19;8(2). pii: 1759091416642351. doi: 10.1177/1759091416642351. Print 2016 Mar-Apr.

21.

Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.

Shin D, Feltri ML, Wrabetz L.

J Neurosci. 2016 Feb 10;36(6):1858-70. doi: 10.1523/JNEUROSCI.3095-15.2016.

22.

Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination.

Poitelon Y, Bogni S, Matafora V, Della-Flora Nunes G, Hurley E, Ghidinelli M, Katzenellenbogen BS, Taveggia C, Silvestri N, Bachi A, Sannino A, Wrabetz L, Feltri ML.

Nat Commun. 2015 Sep 18;6:8303. doi: 10.1038/ncomms9303.

23.

Microprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for schwann cell myelination and myelin maintenance.

Lin HP, Oksuz I, Hurley E, Wrabetz L, Awatramani R.

J Biol Chem. 2015 Oct 2;290(40):24294-307. doi: 10.1074/jbc.M115.636407. Epub 2015 Aug 13.

24.

Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit.

Das I, Krzyzosiak A, Schneider K, Wrabetz L, D'Antonio M, Barry N, Sigurdardottir A, Bertolotti A.

Science. 2015 Apr 10;348(6231):239-42. doi: 10.1126/science.aaa4484.

25.

Disease specific therapies in leukodystrophies and leukoencephalopathies.

Helman G, Van Haren K, Bonkowsky JL, Bernard G, Pizzino A, Braverman N, Suhr D, Patterson MC, Ali Fatemi S, Leonard J, van der Knaap MS, Back SA, Damiani S, Goldman SA, Takanohashi A, Petryniak M, Rowitch D, Messing A, Wrabetz L, Schiffmann R, Eichler F, Escolar ML, Vanderver A; GLIA Consortium.

Mol Genet Metab. 2015 Apr;114(4):527-36. doi: 10.1016/j.ymgme.2015.01.014. Epub 2015 Feb 7.

26.

Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.

Colombelli C, Palmisano M, Eshed-Eisenbach Y, Zambroni D, Pavoni E, Ferri C, Saccucci S, Nicole S, Soininen R, McKee KK, Yurchenco PD, Peles E, Wrabetz L, Feltri ML.

J Cell Biol. 2015 Feb 2;208(3):313-29. doi: 10.1083/jcb.201403111.

27.

Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy.

Vaccari I, Carbone A, Previtali SC, Mironova YA, Alberizzi V, Noseda R, Rivellini C, Bianchi F, Del Carro U, D'Antonio M, Lenk GM, Wrabetz L, Giger RJ, Meisler MH, Bolino A.

Hum Mol Genet. 2015 Jan 15;24(2):383-96. doi: 10.1093/hmg/ddu451. Epub 2014 Sep 3.

28.

Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.

Yin X, Kiryu-Seo S, Kidd GJ, Feltri ML, Wrabetz L, Trapp BD.

Glia. 2015 Jan;63(1):66-77. doi: 10.1002/glia.22733. Epub 2014 Jul 28.

29.

The Gdap1 knockout mouse mechanistically links redox control to Charcot-Marie-Tooth disease.

Niemann A, Huber N, Wagner KM, Somandin C, Horn M, Lebrun-Julien F, Angst B, Pereira JA, Halfter H, Welzl H, Feltri ML, Wrabetz L, Young P, Wessig C, Toyka KV, Suter U.

Brain. 2014 Mar;137(Pt 3):668-82. doi: 10.1093/brain/awt371. Epub 2014 Jan 29.

30.

Deletion of GABA-B receptor in Schwann cells regulates remak bundles and small nociceptive C-fibers.

Faroni A, Castelnovo LF, Procacci P, Caffino L, Fumagalli F, Melfi S, Gambarotta G, Bettler B, Wrabetz L, Magnaghi V.

Glia. 2014 Apr;62(4):548-65. doi: 10.1002/glia.22625. Epub 2014 Jan 29.

31.

Jab1 regulates Schwann cell proliferation and axonal sorting through p27.

Porrello E, Rivellini C, Dina G, Triolo D, Del Carro U, Ungaro D, Panattoni M, Feltri ML, Wrabetz L, Pardi R, Quattrini A, Previtali SC.

J Exp Med. 2014 Jan 13;211(1):29-43. doi: 10.1084/jem.20130720. Epub 2013 Dec 16.

32.

α6β1 and α7β1 integrins are required in Schwann cells to sort axons.

Pellegatta M, De Arcangelis A, D'Urso A, Nodari A, Zambroni D, Ghidinelli M, Matafora V, Williamson C, Georges-Labouesse E, Kreidberg J, Mayer U, McKee KK, Yurchenco PD, Quattrini A, Wrabetz L, Feltri ML.

J Neurosci. 2013 Nov 13;33(46):17995-8007. doi: 10.1523/JNEUROSCI.3179-13.2013.

33.

DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination.

Noseda R, Belin S, Piguet F, Vaccari I, Scarlino S, Brambilla P, Martinelli Boneschi F, Feltri ML, Wrabetz L, Quattrini A, Feinstein E, Huganir RL, Bolino A.

J Neurosci. 2013 Sep 18;33(38):15295-305. doi: 10.1523/JNEUROSCI.2408-13.2013.

34.

Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice.

D'Antonio M, Musner N, Scapin C, Ungaro D, Del Carro U, Ron D, Feltri ML, Wrabetz L.

J Exp Med. 2013 Apr 8;210(4):821-38. doi: 10.1084/jem.20122005. Epub 2013 Apr 1.

35.

Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain.

Orita S, Henry K, Mantuano E, Yamauchi K, De Corato A, Ishikawa T, Feltri ML, Wrabetz L, Gaultier A, Pollack M, Ellisman M, Takahashi K, Gonias SL, Campana WM.

J Neurosci. 2013 Mar 27;33(13):5590-602. doi: 10.1523/JNEUROSCI.3342-12.2013.

36.

Endothelial β4 integrin is predominantly expressed in arterioles, where it promotes vascular remodeling in the hypoxic brain.

Welser-Alves JV, Boroujerdi A, Tigges U, Wrabetz L, Feltri ML, Milner R.

Arterioscler Thromb Vasc Biol. 2013 May;33(5):943-53. doi: 10.1161/ATVBAHA.112.300566. Epub 2013 Mar 7.

37.

Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.

Doddrell RD, Dun XP, Shivane A, Feltri ML, Wrabetz L, Wegner M, Sock E, Hanemann CO, Parkinson DB.

Brain. 2013 Feb;136(Pt 2):549-63. doi: 10.1093/brain/aws353.

38.

Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.

Patzkó A, Bai Y, Saporta MA, Katona I, Wu X, Vizzuso D, Feltri ML, Wang S, Dillon LM, Kamholz J, Kirschner D, Sarkar FH, Wrabetz L, Shy ME.

Brain. 2012 Dec;135(Pt 12):3551-66. doi: 10.1093/brain/aws299. Erratum in: Brain. 2014 Dec;137(Pt 12):e316.

39.

MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.

Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M, Southwood C, Wu X, Gow A, Feltri ML, Wrabetz L, Shy ME.

Brain. 2012 Jul;135(Pt 7):2032-47. doi: 10.1093/brain/aws140. Epub 2012 Jun 10.

40.

Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice.

Wang L, Pytel P, Feltri ML, Wrabetz L, Roos RP.

Neurobiol Dis. 2012 Oct;48(1):52-7. doi: 10.1016/j.nbd.2012.05.014. Epub 2012 Jun 2. Erratum in: Neurobiol Dis. 2013 Jul;55:36.

PMID:
22668777
41.

Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies.

Vaccari I, Dina G, Tronchère H, Kaufman E, Chicanne G, Cerri F, Wrabetz L, Payrastre B, Quattrini A, Weisman LS, Meisler MH, Bolino A.

PLoS Genet. 2011 Oct;7(10):e1002319. doi: 10.1371/journal.pgen.1002319. Epub 2011 Oct 20.

42.

MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains.

Court FA, Zambroni D, Pavoni E, Colombelli C, Baragli C, Figlia G, Sorokin L, Ching W, Salzer JL, Wrabetz L, Feltri ML.

J Neurosci. 2011 Aug 24;31(34):12208-17. doi: 10.1523/JNEUROSCI.0141-11.2011.

43.

Non-redundant function of dystroglycan and β1 integrins in radial sorting of axons.

Berti C, Bartesaghi L, Ghidinelli M, Zambroni D, Figlia G, Chen ZL, Quattrini A, Wrabetz L, Feltri ML.

Development. 2011 Sep;138(18):4025-37. doi: 10.1242/dev.065490.

44.

TACE (ADAM17) inhibits Schwann cell myelination.

La Marca R, Cerri F, Horiuchi K, Bachi A, Feltri ML, Wrabetz L, Blobel CP, Quattrini A, Salzer JL, Taveggia C.

Nat Neurosci. 2011 Jun 12;14(7):857-65. doi: 10.1038/nn.2849.

45.

N-WASp is required for Schwann cell cytoskeletal dynamics, normal myelin gene expression and peripheral nerve myelination.

Jin F, Dong B, Georgiou J, Jiang Q, Zhang J, Bharioke A, Qiu F, Lommel S, Feltri ML, Wrabetz L, Roder JC, Eyer J, Chen X, Peterson AC, Siminovitch KA.

Development. 2011 Apr;138(7):1329-37. doi: 10.1242/dev.058677.

46.

P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice.

Fratta P, Saveri P, Zambroni D, Ferri C, Tinelli E, Messing A, D'Antonio M, Feltri ML, Wrabetz L.

Hum Mol Genet. 2011 Jun 1;20(11):2081-90. doi: 10.1093/hmg/ddr081. Epub 2011 Mar 1.

47.

Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration.

Jung J, Cai W, Lee HK, Pellegatta M, Shin YK, Jang SY, Suh DJ, Wrabetz L, Feltri ML, Park HT.

J Neurosci. 2011 Feb 9;31(6):2009-15. doi: 10.1523/JNEUROSCI.4537-10.2011.

48.

P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice.

Avila RL, D'Antonio M, Bachi A, Inouye H, Feltri ML, Wrabetz L, Kirschner DA.

J Biol Chem. 2010 Dec 31;285(53):42001-12. doi: 10.1074/jbc.M110.166967. Epub 2010 Oct 11.

49.

Foot pad skin biopsy in mouse models of hereditary neuropathy.

Dacci P, Dina G, Cerri F, Previtali SC, Lopez ID, Lauria G, Feltri ML, Bolino A, Comi G, Wrabetz L, Quattrini A.

Glia. 2010 Dec;58(16):2005-16. doi: 10.1002/glia.21069.

50.

MicroRNA-deficient Schwann cells display congenital hypomyelination.

Yun B, Anderegg A, Menichella D, Wrabetz L, Feltri ML, Awatramani R.

J Neurosci. 2010 Jun 2;30(22):7722-8. doi: 10.1523/JNEUROSCI.0876-10.2010.

Supplemental Content

Loading ...
Support Center